| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |